Small molecule drugs are important and efficient components in biological/drug combinations.Small molecules have some considerable advantages over large ones.They can be designed to provide powerful therapeutic effects in small doses, usually less than 10 milligrams or even micrograms.Combined with the sophistication of chemical manufacturing technologies, a smaller number of apis usually translates into lower commodity costs relative to the efficacy of macromolecular therapies.Small molecule drugs have a large amount of expertise and experience in the formulation of highly controlled formulations that can be delivered to specific locations and released over specific periods of time.
This report contains market size and forecasts of Small Molecule API in global, including the following market information:
Global Small Molecule API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Small Molecule API Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Small Molecule API companies in 2021 (%)
The global Small Molecule API market was valued at 159500 million in 2021 and is projected to reach US$ 207480 million by 2028, at a CAGR of 3.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Synthetic & Chemical API Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Small Molecule API include SAFC, Johnson-Matthey, Cambrex, Carbogen-Amcis, Novasep, Fareva, Patheon, AMRI and Almac, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Small Molecule API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Small Molecule API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Small Molecule API Market Segment Percentages, by Type, 2021 (%)
Synthetic & Chemical API
Biological API
Global Small Molecule API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Small Molecule API Market Segment Percentages, by Application, 2021 (%)
Cardiovascular
Tumor
Diabetes
Immune Diseases
Global Small Molecule API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Small Molecule API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Molecule API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Small Molecule API revenues share in global market, 2021 (%)
Key companies Small Molecule API sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Small Molecule API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
SAFC
Johnson-Matthey
Cambrex
Carbogen-Amcis
Novasep
Fareva
Patheon
AMRI
Almac
CordenPharma
Albemarle Corporation
Merck